Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
Becker's Hospital Review1d
FDA green-lights at-home test for 3 STIs
The FDA has granted marketing authorization to Visby Medical for the first at-home diagnostic test for chlamydia, gonorrhea and trichomoniasis that does not require a prescription. The test includes a ...